Showing results (21-30 of 105) with videos related to
Sort By:
Pageof 11
Current Diabetes Reviews|August 12, 2008
Evaluating clinical accuracy of continuous glucose monitoring systems: Continuous Glucose-Error Grid Analysis (CG-EGA)William L Clarke, Stacey Anderson, Boris KovatchevDiabetes Technology & Therapeutics|December 24, 2010
Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulationAchilleas N Pitsillides, Stacey M Anderson, Boris KovatchevIEEE Transactions on Bio-Medical Engineering|August 10, 2021
A Data-Driven Approach to Classifying Daily Continuous Glucose Monitoring (CGM) Time SeriesBenjamin Lobo, Leon Farhy, Mahdi Shafiei, et al.Diabetes Care|October 12, 2018
First Look at Control-IQ: A New-Generation Automated Insulin Delivery SystemSue Brown, Dan Raghinaru, Emma Emory, et al.Journal of Diabetes Science and Technology|September 1, 2009
Glucose Prediction Algorithms from Continuous Monitoring Data: Assessment of Accuracy via Continuous Glucose Error-Grid AnalysisFrancesca Zanderigo, Giovanni Sparacino, Boris Kovatchev, et al.Diabetes, Obesity & Metabolism|November 14, 2018
Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemiaRonnie Aronson, Guillermo Umpierrez, William Stager, et al.Diabetes Care|March 15, 2008
Comparison of the numerical and clinical accuracy of four continuous glucose monitorsBoris Kovatchev, Stacey Anderson, Lutz Heinemann, et al.Journal of Diabetes Science and Technology|December 8, 2019
The Differential and Combined Action of Insulin Glargine and Lixisenatide on the Fasting and Postprandial Components of Glucose ControlThibault Gautier, Guillermo Umpierrez, Eric Renard, et al.Diabetes Technology & Therapeutics|June 7, 2017
Future of Automated Insulin Delivery SystemsJessica R Castle, J Hans DeVries, Boris KovatchevDiabetes Technology & Therapeutics|February 28, 2014
The university of Virginia/Padova type 1 diabetes simulator matches the glucose traces of a clinical trialRoberto Visentin, Chiara Dalla Man, Boris Kovatchev, et al.Pageof 11